Previous close | 7.35 |
Open | 9.30 |
Bid | 9.20 |
Ask | 12.20 |
Strike | 200.00 |
Expiry date | 2024-05-17 |
Day's range | 9.30 - 12.40 |
Contract range | N/A |
Volume | |
Open interest | 661 |
It's been a good week for Biogen Inc. ( NASDAQ:BIIB ) shareholders, because the company has just released its latest...
Sage Therapeutics' (SAGE) first-quarter 2024 results are mixed as earnings miss estimates, but sales beat the mark. The newly-launched depression drug Zurzuvae drives the company's top line.
Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals are part of the Zacks top Analyst Blog.